Patient Discovery Solutions, a leader in patient-provider engagement technologies that harness the voice of the patient and the power of real-world data to improve health equity and achieve better health outcomes, announced the addition of Daniel Uyttebroek to the position of Vice President, Product. In this role, Mr. Uyttebroek will lead the product strategy and design for data and analytics solutions that enable health care teams to tap into previously inaccessible insights and remove barriers to equitable care. 

“We are excited to welcome Dan to Patient Discovery, and we look forward to having his leadership as we work to deliver actionable insights to healthcare stakeholders committed to addressing health equity,” said Jason Shore, Chief Executive Officer and Co-Founder of Patient Discovery. “Integrating the voice of the patient into the solutions we provide is central to our mission as an organization. Dan brings a tremendous amount of industry knowledge and experience, and we feel confident that with his strategic guidance we will be able to ensure better outcomes for every patient.” 

As a product leader and strategist, Mr. Uyttebroek has worked with leading health systems and payers to integrate systems, make sense of their complex data, and thoughtfully disseminate insights across their enterprises and stakeholders. Before joining Patient Discovery, Mr. Uyttebroek was the Senior Director of Product at Arcadia, a leading population health and analytics platform, where he led the product strategy and managed the analytic and data application product portfolio. Prior to Arcadia, he held product management and analytic roles at Optum (NYSE: UNH) and Humedica. 

“Our platform helps patients navigate complex care while also making them feel heard. From a provider standpoint, it enables the entire care team to build tighter relationships with their patients in a personalized way. It also captures insights not provided by any other solution in the market today. With this powerful combination, Patient Discovery is not only helping to build trust between patients and their care teams, but also providing a roadmap for health systems, payers, and biopharmaceutical companies to confront the challenges of ensuring equitable care for every patient,” said Mr. Uyttebroek. “I’m thrilled to be joining a company whose central mission is helping patients and look forward to contributing to our success.”